• Syra has expanded its services to 18 states

CARMEL, Ind., March 28, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today it has secured a healthcare workforce contract in Missouri for providing temporary medical services personnel. Revenue from the contract will be determined based on the number of positions filled and their duration.

The contract encompasses the recruitment of specialized medical professionals crucial to addressing healthcare needs across Missouri. Specifically, the contract mandates the provision of resident physicians, physicians, chief physicians, psychiatrists, and chief psychiatrists, highlighting the various levels of expertise that Syra Health holds as part of its healthcare workforce solutions.

According to a survey by the American Medical Association (AMA), two in five physicians nationwide said they plan to leave practice within five years, with burnout being cited as one of the primary reasons. Physician and psychiatrist roles are typically difficult to fill due to the lack of trained professionals, demanding job responsibilities, and the need for significant experience.

Dr. Deepika Vuppalanchi, CEO, Syra Health, underscored the significance of winning this statewide contract, stating, "We are thrilled to expand our operations into Missouri and further our goal of enhancing healthcare delivery across the nation. This contract not only signifies our continued growth but also reinforces our commitment to providing top-tier medical personnel to meet the evolving needs of healthcare facilities."

Today's contract marks the 18th state where Syra Health has established a presence, reinforcing its commitment to delivering quality healthcare solutions nationwide.

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Health's products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and government. For more information, please visit www.syrahealth.com.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.